![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Company type
Bopharmaceutical company, focuses on the identification, development, commercialization of therapeutic compounds for osteo-renal diseases treatment.Funding rounds
Series C USD 25,300,000
USD 25,300,000 ( )
| Investor | Profile | Country | |
|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
UOB JAIC Venture Bio Investments Ltd |
Series B USD 40,000,000
USD 40,000,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Nomura Holdings Inc | Holding company with controlling stakes in companies that conduct investment and financial services business with an emphasis on securities businesses | Led the round. | |
|
|
JAIC America Inc | |||
|
SMBC Venture Capital Co Ltd (SMBCベンチャーキャピタル) | |||
|
|
Tokio Marine Capital Co Ltd |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
The Bank of Tokyo - Mitsubishi UFJ Capital Co Ltd | Initial investment. |
Investment activity status
Active investor